Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.

Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial. JAMA. 2021 12 28; 326(24):2478-2487.

View in: PubMed

subject areas

Biological Products
Bronchopulmonary Dysplasia
Continuous Positive Airway Pressure
Female
Humans
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases
Male
Phospholipids
Pulmonary Surfactants
Respiratory Distress Syndrome, Newborn
Single-Blind Method

authors with profiles

Matthew Derrick